NO922379L - Farmasoeytisk preparat for regulering av patogene, intestinale bakterier - Google Patents

Farmasoeytisk preparat for regulering av patogene, intestinale bakterier

Info

Publication number
NO922379L
NO922379L NO92922379A NO922379A NO922379L NO 922379 L NO922379 L NO 922379L NO 92922379 A NO92922379 A NO 92922379A NO 922379 A NO922379 A NO 922379A NO 922379 L NO922379 L NO 922379L
Authority
NO
Norway
Prior art keywords
pct
pharmaceutical preparation
bacteries
pathogenes
intestinal
Prior art date
Application number
NO92922379A
Other languages
English (en)
Other versions
NO922379D0 (no
NO303620B1 (no
Inventor
Eva Elisabeth Grahn
Stig Edvin Folke Holm
Original Assignee
Grahn Eva E
Stig Edvin Folke Holm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grahn Eva E, Stig Edvin Folke Holm filed Critical Grahn Eva E
Publication of NO922379D0 publication Critical patent/NO922379D0/no
Publication of NO922379L publication Critical patent/NO922379L/no
Publication of NO303620B1 publication Critical patent/NO303620B1/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56—Platinum group metals
    • B01J23/62—Platinum group metals with gallium, indium, thallium, germanium, tin or lead
    • B01J23/622—Platinum group metals with gallium, indium, thallium, germanium, tin or lead with germanium, tin or lead
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/06—Halogens; Compounds thereof
    • B01J27/08—Halides
    • B01J27/10—Chlorides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/22—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by isomerisation
    • C07C5/2206—Catalytic processes not covered by C07C5/23 - C07C5/31
    • C07C5/226—Catalytic processes not covered by C07C5/23 - C07C5/31 with metals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2521/00—Catalysts comprising the elements, oxides or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium or hafnium
    • C07C2521/02—Boron or aluminium; Oxides or hydroxides thereof
    • C07C2521/04—Alumina
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
    • C07C2523/14—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of germanium, tin or lead
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
    • C07C2523/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals
    • C07C2523/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals of the platinum group metals
    • C07C2523/42—Platinum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
    • C07C2523/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals
    • C07C2523/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals combined with metals, oxides or hydroxides provided for in groups C07C2523/02 - C07C2523/36
    • C07C2523/56—Platinum group metals
    • C07C2523/62—Platinum group metals with gallium, indium, thallium, germanium, tin or lead
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO922379A 1989-12-22 1992-06-17 FremgangsmÕte for fremstilling av et farmas°ytisk preparat for bekjempelse av patogene mikroorganismer i mennesker og dyr NO303620B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8904332A SE465206B (sv) 1989-12-22 1989-12-22 Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
PCT/SE1990/000850 WO1991009608A1 (en) 1989-12-22 1990-12-19 Pharmaceutical preparation for controlling pathogenic intestinal bacteria

Publications (3)

Publication Number Publication Date
NO922379D0 NO922379D0 (no) 1992-06-17
NO922379L true NO922379L (no) 1992-08-12
NO303620B1 NO303620B1 (no) 1998-08-10

Family

ID=20377846

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922379A NO303620B1 (no) 1989-12-22 1992-06-17 FremgangsmÕte for fremstilling av et farmas°ytisk preparat for bekjempelse av patogene mikroorganismer i mennesker og dyr

Country Status (13)

Country Link
US (1) US5322686A (no)
EP (1) EP0506817B1 (no)
JP (1) JP3140049B2 (no)
AT (1) ATE135228T1 (no)
AU (1) AU641722B2 (no)
CA (1) CA2070687C (no)
DE (1) DE69025953T2 (no)
DK (1) DK0506817T3 (no)
ES (1) ES2084806T3 (no)
FI (1) FI96744C (no)
NO (1) NO303620B1 (no)
SE (1) SE465206B (no)
WO (1) WO1991009608A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705152A (en) * 1990-10-26 1998-01-06 Interprise Limited Antimicrobial composition
DK0577903T3 (da) * 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
US5478557A (en) * 1992-07-29 1995-12-26 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5714378A (en) * 1995-03-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Navy Pseudomonas chlororaphis microorganism polyurethane degrading enzyme obtained therefrom and method of using enzyme
AT405235B (de) * 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
GR1002668B (el) * 1996-03-15 1997-04-14 N Μεθοδος προσθηκης στειρου αεριου αζωτου και φαρμακολογικως δραστικων ουσιων εις στερεο γιαουρτι.
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
RU2164801C1 (ru) * 1999-12-06 2001-04-10 Дочернее государственное унитарное экспериментально-производственное предприятие "Вектор-Биальгам" Препарат-пробиотик в сухой иммобилизованной форме
US7820420B2 (en) * 2000-08-11 2010-10-26 Whitlock David R Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
EP1472021A4 (en) * 2002-01-11 2008-04-16 David R Whitlock AMMONIA OXIDIZING BACTERIUM COMPOSITIONS AND METHODS OF USE
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) * 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
FR2883131B1 (fr) * 2005-03-16 2007-04-27 Sarl Caribou T G Sarl Procede de preparation de grains de kefir, et application aux installations de preparation de soupes pour animaux d'elevage
PL1885383T3 (pl) * 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
BRPI0611493B1 (pt) * 2005-05-31 2022-04-05 Alimentary Health Ltd. Lactobacilos probióticos felinos
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2349295B8 (en) * 2008-11-17 2016-12-14 Winclove Holding B.V. Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
JP2017519486A (ja) 2014-04-15 2017-07-20 エーオーバイオーム， エルエルシー．ＡＯＢｉｏｍｅ， ＬＬＣ． アンモニア酸化Ｎｉｔｒｏｓｏｍｏｎａｓ ｅｕｔｒｏｐｈａ株Ｄ２３
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1190386A (en) * 1966-06-28 1970-05-06 Green Cross Corp Process for producing the Lactic Acid Bacteria Drugs
SU1333709A1 (ru) * 1985-11-29 1987-08-30 Всесоюзный Научно-Исследовательский Институт Молочной Промышленности Штамм SтRертососсUS LастIS,используемый в заквасках дл приготовлени кисломолочных продуктов
JPS62201823A (ja) * 1986-02-28 1987-09-05 Freunt Ind Co Ltd 腸内有用細菌含有物およびその製造方法
SU1423586A1 (ru) * 1986-06-09 1988-09-15 Институт Микробиологии И Вирусологии Ан Казсср Способ приготовлени закваски "Казахсил" дл силосовани кормов
US5143845A (en) * 1986-09-03 1992-09-01 Toa Pharmaceutical Co., Ltd. Mixture of saccarifying lactic acid producing and butyric acid producing bacteria
JP2612001B2 (ja) * 1987-09-04 1997-05-21 フロイント産業株式会社 腸内有用細菌含有顆粒およびその製造方法
AU4055689A (en) * 1988-08-03 1990-03-05 Wisconsin Alumni Research Foundation Biological inoculant effective against aphanomyces

Also Published As

Publication number Publication date
DK0506817T3 (da) 1996-04-15
US5322686A (en) 1994-06-21
JP3140049B2 (ja) 2001-03-05
FI922825A0 (fi) 1992-06-17
FI96744B (fi) 1996-05-15
SE8904332D0 (sv) 1989-12-22
JPH05502873A (ja) 1993-05-20
FI922825L (fi) 1992-06-17
WO1991009608A1 (en) 1991-07-11
ATE135228T1 (de) 1996-03-15
NO922379D0 (no) 1992-06-17
CA2070687A1 (en) 1991-06-23
SE8904332L (sv) 1991-06-23
EP0506817B1 (en) 1996-03-13
EP0506817A1 (en) 1992-10-07
FI96744C (fi) 1996-08-26
AU641722B2 (en) 1993-09-30
NO303620B1 (no) 1998-08-10
SE465206B (sv) 1991-08-12
DE69025953D1 (de) 1996-04-18
AU7048291A (en) 1991-07-24
DE69025953T2 (de) 1996-09-05
ES2084806T3 (es) 1996-05-16
CA2070687C (en) 2001-04-10

Similar Documents

Publication Publication Date Title
NO922379D0 (no) Farmasoeytisk preparat for regulering av patogene, intestinale bakterier
SE9702083L (sv) Farmaceutisk beredning för bekämpning av patogena tarmbakterier
PL299543A1 (en) Anti-gastritis and anti-ulcerous agent, biologically active culture of lactic acid bacteria strain and composition containing such agent
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
RU93049638A (ru) Молочно-кислая бактерия
AU2920592A (en) Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections
CA2292706A1 (en) Method for administering viable microorganism composition for poultry
EP0276132A3 (en) Strain of microorganism having antimicrobial activity strain of microorganism having antimicrobial activity
UA43366C2 (uk) Штам бактерій pseudomonas chlororaphis або його біологічно чисті культури, здатні продукувати активні антипатогенні метаболіти, композиція для профілактики захворювань рослин, спосіб профілактики захворювань рослин
FI943387A0 (fi) Mikro-organismiformula ja mikro-organismien käyttö karjanhoidossa
NZ333979A (en) Antiparasitic and insecticidal agents isolated during the fermentation of Nodulisporium
AU6453596A (en) Fungicidal mixtures
IL81857A (en) Insecticidal compositions for controlling scarabid larvae,containing bacterial spored of milky disease bacillus free of sporangia,and in vitro method for producing such spores
ATE299177T1 (de) Milchsäurebakterien und ihre anwendung zur herstellung von hypercholesterolemische aktive produkte
KR950007861A (ko) 항종양제
ATE118674T1 (de) Bioherbizide, die chemische wirkstoffe und pflanzenpathogene bakterien kombinieren.
TW365538B (en) Pharmaceutical composition for preventing a bacterial disease of fishes and crustaceans
FR2739867B1 (fr) Milieux selectifs de culture et d'isolement des bacteries gram-, composition antibiotique
RU92015133A (ru) Консорциум бактерий (lactobacillus salivarius var. salivaris lactobacillus acidophilus, lactobacillus lactis) 3843 для активации фотосинтеза
ATE188485T1 (de) Neuer peptidischer wirkstoff und dessen herstellung
DK612188D0 (da) Antibiotikum a/16686 faktorer a'1, a'2 og a'3, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser
CA2114629A1 (en) Receptor conjugates for targeting antibiotics to bacteria
ES8104402A1 (es) Procedimiento para la preparacion de medicamentos inmunobio-terapicos a partir de cepas microbiologicas.
RU92015134A (ru) Консорциум бактерий (lactobacillus salivarius var. salivaris syreptococcusthermophilus streptococcus bovis) 3844 для активации прорастания семян
NO930675L (no) Anvendelse av et vandig naeringsmedium for formering av homofermentative melkesyrebakterier under usterile betingelser for tilsetning som sileringsmiddel til gjaeret for

Legal Events

Date Code Title Description
MK1K Patent expired